The second part of a 3-part series of blogs on the “Deep phenotyping of post-infectious myalgic encephalomyelitis/chronic fatigue syndrome” study looks at who was in the study and how they were selected, how severely the study was truncated by the pandemic (quite...
“We posit that this assay can potentially offer an outstanding biomarker to rapidly and inexpensively diagnose ME/CFS with high accuracy. In addition, this assay may offer a remarkable opportunity for the discovery of new treatments for this debilitating...
There’s a reason that methylene blue (MB) has a kind of space-age, industrial-type sound to it – its first use was as an industrial chemical. Check out the recent citations on the compound and you’ll find more discussions of nanowires, dye removal,...
Janet Dafoe has been doing an informative series of videos on the Open Medicine Foundation’s work. Her patient-centered approach – she often interrupts a researcher engaging in “research speak” to clarify in simple English what’s going on...
The brain and the blood vessels. So intimately intertwined but so rarely studied together. In retrospect, that’s kind of strange as blood vessels may have more to do with brain functioning than anything else. By weight, the brain is almost a non-entity –...
Clinical trials – once a rarity for chronic fatigue syndrome (ME/CFS) – suddenly seem to be popping up all around the place. The Open Medicine Foundation just announced its first two-fer (two drugs tested together) clinical trial, Solve M.E. has funded at...